Search research articles
Contact Us
Filters
Showing results (251-260 of 361) with videos related to
Page
of 37
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 8, 2020
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement
Are M Holm, Mandeep R Mehra, Andrew Courtwright, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
January 29, 2019
Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis
Manreet K Kanwar, Lisa C Lohmueller, Jeffrey Teuteberg, et al.
Journal of the American College of Cardiology
|
June 27, 2009
Future perspectives for the treatment of pulmonary arterial hypertension
Hossein A Ghofrani, Robyn J Barst, Raymond L Benza, et al.
British Journal of Haematology
|
February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
Robyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
Raymond L Benza, Kelly M Chin, Sean Gaine, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
April 29, 2009
Plasma levels of S100A4 in portopulmonary hypertension
Tien Peng, Roham Zamanian, Michael J Krowka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study
Raymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
Journal of Clinical Medicine
|
January 11, 2022
Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension
Giovanna Manzi, Cristiano Miotti, Marco Valerio Mariani, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 26, 2018
Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Tariq Jamal Siddiqi, et al.
Pulmonary Circulation
|
December 7, 2020
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
Olivier Sitbon, Sylvia Nikkho, Raymond Benza, et al.
Page
of 37
Search research articles
Search
Showing results (251-260 of 361) with videos related to
Sort By:
Page
of 37
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 8, 2020
Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: an ISHLT COVID-19 Task Force statement
Are M Holm, Mandeep R Mehra, Andrew Courtwright, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
January 29, 2019
Risk Assessment in Patients with a Left Ventricular Assist Device Across INTERMACS Profiles Using Bayesian Analysis
Manreet K Kanwar, Lisa C Lohmueller, Jeffrey Teuteberg, et al.
Journal of the American College of Cardiology
|
June 27, 2009
Future perspectives for the treatment of pulmonary arterial hypertension
Hossein A Ghofrani, Robyn J Barst, Raymond L Benza, et al.
British Journal of Haematology
|
February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies
Robyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
Raymond L Benza, Kelly M Chin, Sean Gaine, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
April 29, 2009
Plasma levels of S100A4 in portopulmonary hypertension
Tien Peng, Roham Zamanian, Michael J Krowka, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 1, 2021
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study
Raymond L Benza, Athénaïs Boucly, Harrison W Farber, et al.
Journal of Clinical Medicine
|
January 11, 2022
Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension
Giovanna Manzi, Cristiano Miotti, Marco Valerio Mariani, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 26, 2018
Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Tariq Jamal Siddiqi, et al.
Pulmonary Circulation
|
December 7, 2020
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
Olivier Sitbon, Sylvia Nikkho, Raymond Benza, et al.
Page
of 37